Latigo Biotherapeutics Inc.(LTGO)

Medical - Pharmaceuticals · Thousand Oak, CA

$16.26-0.37 (-2.22%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T20:03:08.128Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:03:08.128Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 978,090,886
Total debt: N/A
Cash: N/A
TTM operating EBITDA: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LTGO EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

LTGO Competitors' EV/EBITDA Ratio

LTGO

Latigo Biotherapeutics Inc.

Current

Market Cap

$978.09M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MGTX

MeiraGTx Holdings plc

vs LTGO

Market Cap

$981.66M

EV/EBITDA Ratio

4.84x

TTM Avg

6.06x

3Y Avg

6.06x

5Y Avg

6.06x

PCRX

Pacira BioSciences, Inc.

vs LTGO

Market Cap

$973.93M

EV/EBITDA Ratio

11.39x

TTM Avg

10.94x

3Y Avg

46.55x

5Y Avg

35.86x

LBRX

LB Pharmaceuticals Inc Common Stock

vs LTGO

Market Cap

$982.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VOR

Vor Biopharma Inc.

vs LTGO

Market Cap

$992.14M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRCT

PROCEPT BioRobotics Corporation

vs LTGO

Market Cap

$996.65M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CGEM

Cullinan Therapeutics, Inc.

vs LTGO

Market Cap

$998.69M

EV/EBITDA Ratio

N/A

TTM Avg

2.11x

3Y Avg

2.11x

5Y Avg

2.11x

AKTS

Aktis Oncology, Inc.

vs LTGO

Market Cap

$953.81M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SVRA

Savara Inc.

vs LTGO

Market Cap

$952.91M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMTX

Immatics N.V.

vs LTGO

Market Cap

$1.01B

EV/EBITDA Ratio

N/A

TTM Avg

21.42x

3Y Avg

21.42x

5Y Avg

21.42x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Latigo Biotherapeutics Inc. (LTGO)	$978.09M	N/A	N/A	N/A	N/A
MeiraGTx Holdings plc (MGTX)vs ›	$981.66M	4.84x	6.06x	6.06x	6.06x
Pacira BioSciences, Inc. (PCRX)vs ›	$973.93M	11.39x	10.94x	46.55x	35.86x
LB Pharmaceuticals Inc Common Stock (LBRX)vs ›	$982.46M	N/A	N/A	N/A	N/A
Vor Biopharma Inc. (VOR)vs ›	$992.14M	N/A	N/A	N/A	N/A
PROCEPT BioRobotics Corporation (PRCT)vs ›	$996.65M	N/A	N/A	N/A	N/A
Cullinan Therapeutics, Inc. (CGEM)vs ›	$998.69M	N/A	2.11x	2.11x	2.11x
Aktis Oncology, Inc. (AKTS)vs ›	$953.81M	N/A	N/A	N/A	N/A
Savara Inc. (SVRA)vs ›	$952.91M	N/A	N/A	N/A	N/A
Immatics N.V. (IMTX)vs ›	$1.01B	N/A	21.42x	21.42x	21.42x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics